Early appetite suppression is common, but visible progress builds gradually over time
Should be taken with the first bite of breakfast, lunch, and dinner the hypoglycemic goal in diabetics typically cannot be met with these drugs alone Side Effects: bloating, gas, abdominal discomfort, diarrhea these side effects develop due to the fermenting of undigested carbohydrate in the colon to fatty acids, with resultant release of gas side effects can diminish over time due to upregulation of -glucosidase in the distal small intestine, which increases glucose absorption & reduces the amount of carbohydrate entering the colon Major drug interactions: ) MAO inhibitors Notes: -glucosidase inhibitors are infrequently prescribed in the US because of their prominent GI side effects & limited ability to lower glucose levels -glucosidases are a family of enzymes with different carbohydrate specificities, and include sucrase, maltase, glucoamylase & dextranase References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Athletes experience significant gains from BPC-157 benefits for athletes, such as faster recovery from intense training, reduced risk of reinjury, and better performance
This peptide operates through several pathways: Attaches to specific receptors in the anterior pituitary gland Triggers the bodys own growth hormone production Elevates IGF-1 levels through downstream effects Enhances tissue restoration, metabolic processes, and sleep architecture The peptides ability to amplify IGF-1 production makes it particularly valuable for individuals focused on tissue repair and regeneration
If prescribed solely for weight loss (an off-label use), coverage is unlikely
Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II)
